Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chronic mucocutaneous candidiasis presenting as refractory fissured tongue in a patient with IL-17RC mutation: the first reported case of Chinese ethnicity. | Emerg Microbes Infect | 2023 | 37395078 | PubTator, text mining | PubMed |
| Immune regulation through tryptophan metabolism. | Exp Mol Med | 2023 | 37394584 | PubTator, text mining | PubMed |
| Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19? | Chin Med J Pulm Crit Care Med | 2023 | 37388822 | PubTator, text mining | PubMed |
PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification. | Front Immunol | 2023 | 37388747 | PubTator, text mining | PubMed |
| Keratinoctye-neuro-immune-units (KNICUs): collaborative impact on the initiation and maintenance of psoriasis. | Front Med (Lausanne) | 2023 | 37387780 | PubTator, text mining | PubMed |
| Network pharmacology and molecular docking reveal the mechanism of Qinghua Xiaoyong Formula in Crohn's disease. | Korean J Physiol Pharmacol | 2023 | 37386834 | PubTator, text mining | PubMed |
| Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial. | PLoS Med | 2023 | 37384596 | PubTator, text mining | PubMed |
| Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. | Cancer Biol Med | 2023 | 37381714 | PubTator, text mining | PubMed |
| The central inflammatory regulator IκBζ: induction, regulation and physiological functions. | Front Immunol | 2023 | 37377955 | PubTator, text mining | PubMed |
| Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022. | Breathe (Sheff) | 2023 | 37377851 | PubTator, text mining | PubMed |
| Toward a Systematic Assessment of Sex Differences in Cystic Fibrosis. | J Pers Med | 2023 | 37373913 | PubTator, text mining | PubMed |
| Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease. | Int J Mol Sci | 2023 | 37373554 | PubTator, text mining | PubMed |
| Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies. | Int J Mol Sci | 2023 | 37373452 | PubTator, text mining | PubMed |
| Drug Target Identification and Drug Repurposing in Psoriasis through Systems Biology Approach, DNN-Based DTI Model and Genome-Wide Microarray Data. | Int J Mol Sci | 2023 | 37373186 | PubTator, text mining | PubMed |
| The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37373022 | PubTator, text mining | PubMed |
| Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine. | Int J Mol Sci | 2023 | 37372997 | PubTator, text mining | PubMed |
| JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus. | Genes (Basel) | 2023 | 37372319 | PubTator, text mining | PubMed |
| Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives. | Biomedicines | 2023 | 37371647 | PubTator, text mining | PubMed |
Genetic and Epigenetic Host-Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach. | Biomedicines | 2023 | 37371627 | PubTator, text mining | PubMed |
| The Influence of Sex Hormones in Liver Function and Disease. | Cells | 2023 | 37371074 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=26